S
Satish Shanbhag
Researcher at Johns Hopkins University School of Medicine
Publications - 46
Citations - 1567
Satish Shanbhag is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Medicine & Rituximab. The author has an hindex of 15, co-authored 42 publications receiving 928 citations. Previous affiliations of Satish Shanbhag include Fox Chase Cancer Center & Johns Hopkins Bayview Medical Center.
Papers
More filters
Journal ArticleDOI
Hodgkin lymphoma: A review and update on recent progress.
TL;DR: Alternative donor sources and reduced‐intensity conditioning have made allogeneic hematopoietic stem cell transplantation a viable option for more patients and future research will look to integrate novel strategies into earlier lines of therapy to improve the HL cure rate and minimize long‐term treatment toxicities.
Journal ArticleDOI
Society for immunotherapy of cancer (sitc) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Julie R. Brahmer,Hamzah Abu-Sbeih,Paolo A. Ascierto,Jill Brufsky,Laura C. Cappelli,Frank B. Cortazar,David E. Gerber,Lamya Hamad,Eric Hansen,Douglas B. Johnson,Mario E. Lacouture,Gregory A. Masters,Jarushka Naidoo,Jarushka Naidoo,Michele Nanni,Miguel-Angel Perales,Igor Puzanov,Bianca Santomasso,Satish Shanbhag,Rajeev Sharma,Dimitra Skondra,Jeffrey A. Sosman,Michelle Turner,M. S. Ernstoff +23 more
TL;DR: In this paper, the authors presented evidence-and consensus-based guidelines for the management of immune-related adverse events (irAEs) during ICI treatment, which were developed by the Society for Immunotherapy of Cancer (SITC).
Journal ArticleDOI
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon,Javier Bolaños-Meade,Gabrielle T. Prince,Hua Ling Tsai,Shannon R. McCurdy,Jennifer A. Kanakry,Gary L. Rosner,Robert A. Brodsky,Karlo Perica,B. Douglas Smith,Douglas E. Gladstone,Lode J. Swinnen,Margaret M. Showel,William Matsui,Carol Ann Huff,Ivan Borrello,Keith W. Pratz,Michael A. McDevitt,Ivana Gojo,Amy E. DeZern,Satish Shanbhag,Mark J. Levis,Leo Luznik,Richard F. Ambinder,Ephraim J. Fuchs,Richard J. Jones +25 more
TL;DR: NMA haplo-BMT with post-transplantation cyclophosphamide has encouraging safety and survival outcomes in patients age 50 to 75 years, and in patients otherwise fit for BMT, the results support consideration of this approach despite advanced age.
Journal ArticleDOI
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.
Michael S. Khodadoust,Alain H. Rook,Pierluigi Porcu,Francine M. Foss,Alison J. Moskowitz,Andrei R. Shustov,Satish Shanbhag,Lubomir Sokol,Steven P. Fling,Nirasha Ramchurren,Robert H. Pierce,Asa Davis,Richard Shine,Shufeng Li,Sophia Fong,Jinah Kim,Yi Yang,Wendy M. Blumenschein,Jennifer H. Yearley,Biswajit Das,Rajesh Patidar,Vivekananda Datta,Erin Cantu,Justine N. McCutcheon,Chris Karlovich,P. Mickey Williams,Priyanka B. Subrahmanyam,Holden T. Maecker,Steven M. Horwitz,Elad Sharon,Holbrook E Kohrt,Martin A. Cheever,Youn H. Kim +32 more
TL;DR: Pembrolizumab demonstrated significant antitumor activity with durable responses and a favorable safety profile in patients with advanced MF/SS.
Journal ArticleDOI
Modified Ham test for atypical hemolytic uremic syndrome.
Eleni Gavriilaki,Xuan Yuan,Zhaohui Ye,Alexander J. Ambinder,Satish Shanbhag,Michael B. Streiff,Thomas S. Kickler,Alison R. Moliterno,C. John Sperati,Robert A. Brodsky +9 more
TL;DR: A novel assay based on the hypothesis that paroxysmal nocturnal hemoglobinuria cells are more sensitive to APC-activated serum due to deficiency of glycosylphosphatidylinositol- anchored complement regulatory proteins (GPI-AP) is developed that shows high reproducibility, sensitivity, and specificity in detecting aHUS.